Folgen
-
In this episode, learn how early and sustained HBV care can be enhanced by expanding the role of primary care providers in HBV management. Learn how to:
Engage key stakeholders in the provision of HBV careProvide HBV management resources to support PCPs who are doing screeningConsider specialty and primary care collaborations that empower PCPs with clear guidance on how to manage patients living with HBVPresenters:
Su Wang, MD, MPH, FACP
Medical Director
Center for Asian Health and Viral Hepatitis Programs
Cooperman Barnabas Medical Center
RWJBarnabas-Rutgers Medical Group
Associate Member
Health Care Policy and Aging Research
The Rutgers Institute for Health
Senior Advisor
Global Health, Hepatitis B Foundation
Florham Park, New JerseyRichard R. Andrews, MD, MPH
President, Houston Viral Hepatitis Task Force
Former Co-Chair, National Task Force on Hepatitis B
Board-Certified Family Medicine
Addiction Medicine Physician
Houston, TexasRuth Brogden, MPH
Patient AdvocateAmy S. Tang, MD
Former Co-Chair, National Task Force on Hepatitis B
Director of Immigrant Health
North East Medical Services
San Francisco, CaliforniaLink to full program:
https://bit.ly/3TuqFHILink to the slides:
https://bit.ly/44hXpHuGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.
-
In this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include:
Patient subgroups to consider for treatment outside guideline criteriaAdverse event and cost-effectiveness considerationsIntegration of patient perspectives in wider treatmentPresenters:
Mark S. Sulkowski, MD, FIDSA, FAASLD
Professor of Medicine
Director, Division of Infectious Diseases, Johns Hopkins Bayview Medical Center
Johns Hopkins University School of Medicine
Baltimore, MarylandTatyana Kushner, MD, MSCE
Associate Professor
Division of Liver Diseases
Icahn School of Medicine at Mount Sinai
New York, New YorkPaul Y. Kwo, MD
Professor of Medicine
Director of Hepatology
Stanford University School of Medicine
Palo Alto, CaliforniaJacki Chen, PhD
Patient AdvocateLink to full program:
https://bit.ly/3TuqFHILink to the slides:
https://bit.ly/4a60GM4Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.
-
Fehlende Folgen?
-
In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include:
Updated CDC recommendations for one-time universal screening for HBVAddressing patient-, provider-, and system-level barriers to universal HBV screeningBest practices for implementation of HDV screeningPresenters:
Douglas Dieterich, MD
Director, Institute for Liver MedicineProfessor of Medicine
Division of Liver Diseases
Mount Sinai School of Medicine
New York, New York
Camilla S. Graham, MD, MPH
Co-Director, Viral Hepatitis Clinic
Division of Infectious Diseases
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, MassachusettsRobert Wong, MD, MS
Clinical Associate Professor
Division of Gastroenterology and Hepatology
Stanford University School of Medicine
Palo Alto, CaliforniaLink to full program:
https://bit.ly/3TuqFHILink to the slides:
https://bit.ly/4atS42z -
In this podcast, Julie Ann Justo, PharmD, MS, FIDSA, BCPS, discusses treatment of carbapenem-resistant Enterobacterales (CRE) infections, including:
Burden of CRE infections in the United StatesMechanisms of resistanceChanging epidemiologyUse of rapid diagnostic testsIDSA guidance recommendations, including supporting dataApproach to designing treatment regimens, including weighing patient- and infection-related factorsFaculty:
Julie Ann Justo, PharmD, MS, FIDSA, BCPS
Clinical Pharmacist Lead – Infectious Diseases
Inpatient Pharmacy
Dartmouth Hitchcock Medical Center
Lebanon, New HampshireLink to full program:
https://bit.ly/41a8Mj0Link to accompanying ClinicalThought commentary:
https://bit.ly/4865T57Link to downloadable infographic:
https://bit.ly/3t7NpT2 -
In this accredited podcast episode, Dr Christina Madison and Dr Mary Bridgeman provide practical strategies for implementing RSV vaccination into practice, including:
Educating older adults on RSV vaccines Providing effective, evidence-based recommendationsShared decision-making Identifying and addressing vaccine hesitancy Proactive strategies in vaccinating for RSV Predicting and overcoming barriers to RSV vaccinationPresenters:
Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAP
Clinical Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
Internal Medicine Pharmacist
Robert Wood Johnson University Hospital
New Brunswick, New JerseyChristina M. Madison, PharmD, FCCP, AAHIVP
Clinical Pharmacist
Founder and CEO, The Public Health Pharmacist, PLLC
Adjunct Associate Professor of Pharmacy Practice
Roseman University of Health Sciences
College of Pharmacy
Henderson, NevadaOther program activities:
Frontiers in RSV Prevention for Older Adults: Developments, Recommendations, and the Pharmacist’s Role
https://bit.ly/49GUv1gLink to CME: Claim Credit –
https://bit.ly/3uoY7VH[After selecting the “Continue to Post Test” button:]
To receive continuing education credit, submit your posttest answers no later than the expiration of this activity. Select the best answer to each question. When you have completed all the questions, press the "Continue" button at the bottom.
-
In this accredited podcast episode, Dr Christina Madison and Dr Mary Bridgeman discuss the latest practical strategies for preventing RSV infection in older adults, including:
Role of basic public health precautionsAvailable and emerging vaccinesMechanisms of action, therapeutic targets, and pharmacologyEfficacy and safety dataFDA approval status and ACIP recommendationsPresenters:
Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAP
Clinical Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
Internal Medicine Pharmacist
Robert Wood Johnson University Hospital
New Brunswick, New JerseyChristina M. Madison, PharmD, FCCP, AAHIVP
Clinical Pharmacist
Founder and CEO, The Public Health Pharmacist, PLLC
Adjunct Associate Professor of Pharmacy Practice
Roseman University of Health Sciences
College of Pharmacy
Henderson, NevadaOther program activities:
• Frontiers in RSV Prevention for Older Adults: Developments, Recommendations, and the Pharmacist’s Role
-
In this accredited podcast episode, Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAP, discusses the most important things for pharmacists across all settings to know about RSV infections in patients 60 years of age or older, including:
Incidence and prevalence of RSV in older adults, including hospitalization, mortality, epidemiologySeasonalityClinical manifestationsRisk factors for severe outcomesVulnerable groups and comorbiditiesPresenter:
Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAP
Clinical Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
Internal Medicine Pharmacist
Robert Wood Johnson University Hospital
New Brunswick, New JerseyOther program activities:
Frontiers in RSV Prevention for Older Adults: Developments, Recommendations, and the Pharmacist’s Role
https://bit.ly/49GUv1gLink to CME: Claim Credit – https://bit.ly/47GtNnK
[After selecting the “Continue to Post Test” button:]To receive continuing education credit, submit your posttest answers no later than the expiration of this activity. Select the best answer to each question. When you have completed all the questions, press the "Continue" button at the bottom.
-
In this episode, Sarah Hayward, PharmD, BCOP, and Amy Ly Indorf, PharmD, BCOP, discuss their experiences providing care for patients with advanced ovarian cancer, with topics including:
PARP inhibitors as frontline maintenance therapyPatient education and counseling on PARP inhibitorsHelping patients access newer therapiesExperiences with mirvetuximab soravtansinePatient education and counseling on mirvetuximab soravtansineTreatment modalities on the horizon
Presenters:Sarah Hayward, PharmD, BCOP
Clinical Pharmacy Specialist,
Gynecologic Oncology
Stephenson Cancer Center at
OU Health
Oklahoma City, OklahomaAmy Ly Indorf, PharmD, BCOP
Clinical Assistant Professor
University of Washington
School of Pharmacy
Clinical Oncology Pharmacist
UW Medicine
Fred Hutchinson Cancer Center
Seattle, WashingtonSupported by educational grants from GSK and Novocure, Inc.
Link to full program:
https://bit.ly/44fUiOU -
In this episode, Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, discuss strategies for managing ambulatory patients with acute or previous COVID-19 infection, including:
Current COVID-19 landscapeRapid antigen tests and PCR testsRisk stratification of patients who have a positive SARS-CoV-2 testAntiviral treatment (nirmatrelvir + ritonavir, remdesivir, and molnupiravir)Long COVIDPresenters:
Renslow Sherer, MD
Director, International HIV Training Center
Professor of Medicine
Section of Infectious Diseases and Global Health
Department of Medicine
University of Chicago
Chicago, IllinoisTrinh P. Vu, PharmD, BCIDP
Clinical Pharmacy Specialist in Infectious Diseases
Department of Pharmaceutical Services
Emory University Hospital Midtown
Atlanta, GeorgiaTo download the slides: bit.ly/3oHKC09
To view the full online program: bit.ly/4201xcO
-
In this episode, pharmacists Kristi W. Kelley, PharmD, FCCP, BCPS, BCACP, CDCES, BC-ADM, and Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP, discuss the use of GLP-1 receptor agonists in patients with type 2 diabetes and provide answers to commonly asked questions. Listen to their conversation about the differences between short-acting vs long-acting agents; the benefits of use in combination with other medications, such as SGLT2 inhibitors, DPP-4 inhibitors, and metformin; their benefits in heart failure; and their role in the updated consensus statement from the American Diabetes Association/European Association for the Study of Diabetes.
Presenters:
Kristi W. Kelley, PharmD, FCCP, BCPS, BCACP, CDCES, BC-ADM
Clinical Professor
Department of Pharmacy Practice
Auburn University Harrison College of Pharmacy
Clinical Pharmacist
Baptist Health Foundation Center for Medical and Surgical Care
Princeton Baptist Medical Center/Brookwood Baptist Health
Birmingham, AlabamaChristie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP
Professor
Department of Pharmacy Practice
Midwestern University
College of Pharmacy
Downers Grove, Illinois
Clinical Pharmacist
Advocate Medical Group
Chicago, IllinoisContent based on an online CE program supported by an educational grant from Novo Nordisk, Inc.
Link to full program:
https://bit.ly/3Un1xQi -
In this episode, Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP, and Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, discuss the use of mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes, including:
Overview of chronic kidney diseaseGuideline recommendationsEvidence for finerenoneRole of the pharmacistPresenter:
Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP
Endocrine Clinical Pharmacy Specialist
CGM and Remote Monitoring Program Coordinator
Endocrinology and Metabolism Institute
Cleveland Clinic
Cleveland, OhioJoshua J. Neumiller, PharmD, CDCES, FADCES, FASCP
Vice Chair and Allen I. White Distinguished Professor
Department of Pharmacotherapy
College of Pharmacy and Pharmaceutical Sciences
Washington State University
Spokane, WashingtonReview the downloadable slideset and the full program at:
https://bit.ly/3wxNAod -
This podcast is the third in a series of three featuring insights from expert cardiology pharmacists on nonvalvular atrial fibrillation (NVAF). In this episode, pharmacist Kathleen A. Lusk, PharmD, BCPS, BCCP, provides an overview of health disparities, patient engagement, and collaborative team-based care to optimize outcomes for patients with NVAF. Dr Lusk reviews best practices in using the principles of motivational interviewing to employ shared decision-making and models these strategies with 2 simulated clinical patient visits. Common barriers, such as medication access and adherence, also are discussed, along with practical solutions for overcoming these care obstacles.
Presenter:
Kathleen A. Lusk, PharmD, BCPS, BCCP
Associate Professor and Vice Chair
Department of Pharmacy Practice
University of the Incarnate Word Feik School of Pharmacy
Adjunct Assistant Professor
Clinical Pharmacy Specialist
Division of Cardiology
Department of Medicine
UT Health San Antonio
San Antonio, TexasContent is based on an online CE program supported by an educational grant from the Bristol Myers Squibb Pfizer Alliance.
This podcast series was first delivered as live webinars, which are now available as on-demand, CE-certified microlearning modules with downloadable slidesets. The program also features a ClinicalThought commentary and a downloadable infographic reference guide. To access the full program, go to:
https://bit.ly/3OMazV8 -
This podcast is the first in a series of three featuring cardiology pharmacists Kathleen A. Lusk, PharmD, BCPS, BCCP, and Stephanie Dwyer Kaluzna, PharmD, BCCP. In this episode, Drs Lusk and Dwyer Kaluzna provide an overview of nonvalvular atrial fibrillation (NVAF), including prevalence, burden, and consequences of undiagnosed NVAF and the role of pharmacists in screening for the condition in various pharmacy settings.
Presenters:
Kathleen A. Lusk, PharmD, BCPS, BCCP
Associate Professor and Vice Chair
Department of Pharmacy Practice
University of the Incarnate Word Feik School of Pharmacy
Adjunct Assistant Professor
Clinical Pharmacy Specialist
Division of Cardiology
Department of Medicine
UT Health San Antonio
San Antonio, TexasStephanie Dwyer Kaluzna, PharmD, BCCP
Clinical Assistant Professor
Department of Pharmacy Practice
University of Illinois Chicago College of Pharmacy
Cardiovascular Clinical Pharmacist
University of Illinois Hospital and Health Science System
Chicago, IllinoisContent is based on an online CE program supported by an educational grant from the Bristol Myers Squibb Pfizer Alliance.
This podcast series was first delivered as live webinars, which are now available as on-demand, CE-certified microlearning modules with downloadable slidesets. The program also features a ClinicalThought commentary and a downloadable infographic reference guide. To access the full program, go to
https://bit.ly/3OMazV8 -
This podcast is the second in a series of three featuring insights from expert cardiology pharmacists on nonvalvular atrial fibrillation (NVAF). In this episode, cardiology pharmacist Stephanie Dwyer Kaluzna, PharmD, BCCP, reviews key literature and guideline recommendations for stroke prevention in patients with NVAF. Dr Dwyer Kaluzna discusses the most recent evidence for prescribing, dosing, and monitoring direct oral anticoagulants (DOACs); using the risk-screening tools HAS-BLED and CHA2DS2-VASc to design patient-specific pharmacotherapy plans; and the use of DOACs in special patient populations, including older patients, patients with end-stage renal disease, and patients with low or high body weights.
Presenter:
Stephanie Dwyer Kaluzna, PharmD, BCCP
Clinical Assistant Professor
Department of Pharmacy Practice
University of Illinois Chicago College of Pharmacy
Cardiovascular Clinical Pharmacist
University of Illinois Hospital and Health Science System
Chicago, IllinoisContent is based on an online CE program supported by an educational grant from the Bristol Myers Squibb Pfizer Alliance.
This podcast series was first delivered as live webinars, which are now available as on-demand, CE-certified microlearning modules with downloadable slidesets. The program also features a ClinicalThought commentary and a downloadable infographic reference guide. To access the full program, go to
https://bit.ly/3OMazV8 -
In this episode, pharmacists Megan Adelman, PharmD, BCPS, BCGP, CDCES, and Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, BCGP, FASCP, FAzPA, provide an overview of obesity, including pathophysiology and the benefits of long-term weight loss, and discuss guideline recommendations for treatment, pharmacotherapy options including injectable agents, and overcoming barriers to care.
Presenters:
Megan Adelman, PharmD, BCPS, BCGP, CDCES
Family Medicine Clinical Specialist
Center for Family Medicine
Cleveland Clinic Akron General
Akron, OhioElizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, BCGP, FASCP, FAzPA
Professor
Department of Pharmacy Practice
College of Pharmacy-Glendale
Midwestern University
Glendale, ArizonaContent based on an online CE program supported by an educational grant from Novo Nordisk, Inc.
Link to full program:
https://bit.ly/3EAARVu -
Faculty
Tyree H. Kiser, PharmD, FCCM, FCCP, BCCCP, BCPS
Professor, Department of Clinical Pharmacy
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Critical Care Pharmacy Specialist, Department of Pharmacy
University of Colorado Hospital
Aurora, Colorado
Charles E. “Kurt” Mahan, PharmD, PhC, FASHP, FCCP
Adjunct Associate Professor, Pharmacy
University of New Mexico Health Sciences Center
Albuquerque, New Mexico
Content based on a CE activity supported by an educational grant from Alexion, AstraZeneca Rare Disease.
Link to full activity: https://www.proce.com/Anticoagulation
-
1:08 - Take-home thoughts for R/R MM
3:47 - Summary of BCMA-targeted CAR T-cell therapy; Use of novel agents for R/R MM
6:47 - Information on melphalan flufenamide; Combination approaches with selinexor in clinical practice
9:59 - Cost considerations for treatment options in R/R MM
12:25 - Administration considerations for subcutaneous daratumumab and venetoclax in R/R MMFaculty
Kathryn Maples, PharmD, BCOP
Clinical Pharmacy Specialist, Multiple Myeloma
Winship Cancer Institute, Emory Healthcare
Atlanta, Georgia
Tim Peterson, PharmD, BCOP
Clinical Pharmacy Specialist – Multiple Myeloma
Memorial Sloan Kettering Cancer Center
New York, New York
Content based on a CE activity supported by educational grants from Karyopharm Therapeutics, Inc. and Oncopeptides, Inc.
Link to full activity:
https://www.proce.com/RRMM
